These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study. Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984 [TBL] [Abstract][Full Text] [Related]
11. The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus. Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ Intern Med J; 2017 Nov; 47(11):1263-1269. PubMed ID: 28516725 [TBL] [Abstract][Full Text] [Related]
12. Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease. Zhang H; Zhao S; Cao Z Front Immunol; 2022; 13():1001055. PubMed ID: 36389673 [TBL] [Abstract][Full Text] [Related]
13. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease. Long MD; Martin C; Sandler RS; Kappelman MD Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738 [TBL] [Abstract][Full Text] [Related]
14. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease. deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205 [TBL] [Abstract][Full Text] [Related]
15. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience. Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834 [TBL] [Abstract][Full Text] [Related]
16. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines. Kopylov U; Levin A; Mendelson E; Dovrat S; Book M; Eliakim R; Ben-Horin S Aliment Pharmacol Ther; 2012 Jul; 36(2):145-50. PubMed ID: 22612376 [TBL] [Abstract][Full Text] [Related]
17. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891 [TBL] [Abstract][Full Text] [Related]
18. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review. Subramaniam K; D'Rozario J; Pavli P J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824 [TBL] [Abstract][Full Text] [Related]
19. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
20. Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Shukla T; Singh S; Tandon P; McCurdy JD J Clin Gastroenterol; 2017; 51(5):394-401. PubMed ID: 27875356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]